Abstract
Introduction. A clinical and economic study was carried out to assess the effectiveness of infertility treatment using assisted reproductive technology programs with preimplantation genetic testing (PGT) in patients with various reproductive disorders.
Materials and methods. Twenty models representing discrete-time Markov processes are developed. A total of 10 possible paired scenarios for couples undergoing infertility treatment using assisted reproductive technology, depending on reproductive disorders and the use of PGT, were considered in the study.
Results. The most cost-effective scenarios from the simulation results should be the use of PGT in the group of females aged 3742 years and in the group of females under 35 years with missed abortion. These scenarios are not only resource-efficient in terms of the willingness-to-pay threshold, but they also preserve compulsory health insurance funds still with meaningful clinical efficiency. The remaining scenarios are characterized by significant clinical efficacy and low cost per added live birth, except for the PGT use in the group of males with teratozoospermia, which is characterized by a minimum of added live births and a maximum cost per added live birth.
Conclusion. The study results indicate the most optimal and economically feasible scenarios of PGT in patients depending on the infertility factor for implementation in the practical healthcare system of the Russian Federation.
Subject
Obstetrics and Gynecology
Reference14 articles.
1. Significance of preimplantation genetic testing for aneuploidy in assisted reproductive technology programs
2. МЗ РФ 05 марта 2019 г. №15-4/и/2-1908. Вспомогательные репродуктивные технологии и искусственная инсеминация. Клинические рекомендации (протокол лечения) [MZ RF 05 marta 2019 g. №15-4/i/2-1908. Vspomogatel'nye reproduktivnye tekhnologii i iskusstvennaia inseminatsiia. Klinicheskie rekomendatsii [protokol lecheniia] (in Russian)].
3. Dahdouh EM. Preimplantation Genetic Testing for Aneuploidy. Obstet Gynecol. 2021;137(3):528-34.
4. Holmqvist V, Roos LKS, Kjartansdottir KR, et al. Preimplantation genetic testing for aneuploidy. Ugeskr Laeger. 2019;181(20).
5. Michaan N, Leshno M, Cohen Y, et al. Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis. Reprod Biol Endocrinol. 2021;19(1):153.